The stock increased 0.24% or $0.07 during the last trading session, reaching $29.71. About 62,780 shares traded.
Theravance Biopharma (NASDAQ:TBPH) last released its earnings results on Tuesday, November 7th. It has outperformed by 10.12% the S&P500.
Theravance Biopharma, Inc is a biopharmaceutical company.
In an overview of the current analyst recommendations, Buy count is 1 and Overweight is 1 while the number of analysts recommending Sell and Underweight are 0 and 0, respectively. After $-1.27 actual EPS reported by Theravance Biopharma, Inc. for the previous quarter, Wall Street now forecasts -9.45 % EPS growth. The stock decreased 0.55% or $0.03 during the last trading session, reaching $5.46. About 121,714 shares traded.
JPMorgan Chase & Co. cut its holdings in Theravance Biopharma Inc (NASDAQ:TBPH) by 98.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. It has outperformed by 73.15% the S&P500.The move comes after 9 months negative chart setup for the $1.56 billion company.
Since September 6, 2017, it had 0 insider purchases, and 1 sale for $451,350 activity. If the ratio is less than 1, then we can determine that there has been a decrease in price. Its down 0.01, from 0.92 in 2017Q2. 7 funds opened positions while 34 raised stakes. The institutional investors in our partner's database reported: 35.46 million shares, up from 34.25 million shares in 2017Q2. Invesco Ltd owns 56,860 shares. Gotham Asset Llc reported 7,962 shares or 0.01% of all its holdings. (NYSE:STI). Schwab Charles Inv Mgmt Inc holds 0.08% or 1.61 million shares in its portfolio. State Street Corp grew its stake in Theravance Biopharma by 2.2% during the second quarter. (NASDAQ:TBPH). Foundation Asset Management L P holds 4.61% or 432,532 shares in its portfolio. Envestnet Asset has invested 0% in Theravance Biopharma, Inc. The ratio is calculated by dividing the stock price per share by the book value per share. Janney Montgomery Scott Ltd Liability has 42,419 shares. Moreover, Deutsche Comml Bank Ag has 0% invested in Theravance Biopharma, Inc. Riverhead Cap Mngmt Ltd Liability reported 33,811 shares. Vanguard Group Inc. now owns 3,197,277 shares of the biopharmaceutical company's stock worth $127,379,000 after buying an additional 116,981 shares during the last quarter. (NYSE:STI). Of Virginia Va holds 0.08% or 8,803 shares in its portfolio. Therefore 65% are positive. The company presently has a consensus rating of Hold and a consensus price target of $41.86. The firm earned "Buy" rating on Friday, September 15 by Needham. The rating was upgraded by Portales Partners to "Outperform" on Tuesday, June 28.
Taliban kill seven people including six children in Afghanistan
Among those killed are three boys, a woman, a girl and a boy. "The children were between 1 and 12 years old", Noori said. Taliban however has rejected the claims saying that the rocket was not fired by them.
A New Cold War? China Declares Itself a 'Near-Arctic State'
Instead, it enjoys observer status in the Arctic Council, whose core members include Denmark, Sweden, Norway, Iceland, Finland, Russia and the US.
Jacob Rees-Mogg and Philip Hammond at odds over Brexit
Rees-Mogg argued that would make Britain "be a vassal of the European Union ", bound by its rules but with no say in making them. The Eurosceptic backbencher said in a speech that "close alignment" with the European Union after Brexit would be unacceptable.
The Gross Margin Score is calculated by looking at the Gross Margin and the overall stability of the company over the course of 8 years. (NASDAQ:TBPH) on Monday, October 30 with "Sell" rating. (TBPH). The consensus rating is 2.9, suggesting the market has given up on the stock. The stock of Johnson Outdoors Inc. Evercore has "Buy" rating and $45.0 target. (NYSE:STI) rating on Friday, September 29. Also, the Hold rating count is 3 as of 01/23/18.
SunTrust Banks, Inc. operates as the holding firm for SunTrust Bank that provides various financial services for consumers, businesses, firms, and institutions in the United States. It has a 17.86 P/E ratio. Theravance Biopharma had a negative net margin of 1,604.87% and a negative return on equity of 99.43%. analysts expect that Theravance Biopharma will post -4.84 earnings per share for the current year. Therefore 100% are positive. ValuEngine lowered Theravance Biopharma from a "hold" rating to a "sell" rating in a research report on Tuesday, November 14th. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company's stock. The stock has "Sell" rating by Robert W. Baird on Monday, September 18. Needham maintained Theravance Biopharma, Inc. (NASDAQ:TBPH). Northern Trust Corporation reported 526,295 shares. The firm has "Buy" rating by J.P. Morgan given on Friday, July 14. Robert W. Baird downgraded it to "Underperform" rating and $24 target in Wednesday, October 12 report. The firm has "Buy" rating given on Wednesday, August 16 by Evercore.
Theravance Biopharma, Inc is a biopharmaceutical company. (NASDAQ:TBPH) earned "Overweight" rating by Piper Jaffray on Thursday, November 3. Leerink Swann initiated it with "Outperform" rating and $26 target in Thursday, May 12 report. BidaskClub upgraded shares of Theravance Biopharma from a "strong sell" rating to a "sell" rating in a report on Saturday, January 20th.
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and commercializes human therapeutics. The company has market cap of $108.10 million. The firm offers VIBATIV, a bactericidal, once-daily injectable antibiotic to treat patients with infections due to Staphylococcus aureus and other Gram-positive bacteria. (NasdaqGM:XLRN) is -19.192538. This ratio is found by taking the current share price and dividing by earnings per share. The Company's products include voretigene neparvovec, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or biallelic mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.
Recommended News
-
26 January 2018Sea of Thieves beta extended by 2 days
For instance, the "Too Early" fix, although released, is taking longer than anticipated to reach all affected players. But it seemed to be a permissions problem accessing the game, rather than sheer weight of numbers that caused issues.26 January 2018CT says NCAA investigating men's basketball program
This season, the Huskies have struggled are now 11-9 and 4-3 in the American Athletic Conference after Thursday's 63-52 win over SMU.HollyFrontier Corp (NYSE:HFC) CAO Sells 11000 Shares of Stock
Tudor Pickering downgraded HollyFrontier from a buy rating to a hold rating in a research report on Wednesday, November 29th. The stock of HollyFrontier Corporation (NYSE:HFC) has "Buy" rating given on Wednesday, December 20 by RBC Capital Markets. -
26 January 2018What the new iOS 11.3 will bring
The app will help customers with useful information such as a business description, email or store addresses, and website. Most of the focus on Apple externally relates to the expected changes to the Settings area around Battery health.Today's Brokerage Rating: Autodesk, Inc. (ADSK), Amicus Therapeutics, Inc. (FOLD)
Citadel Ltd Liability Corp accumulated 1.39M shares. 17,660 are held by Tiedemann Wealth Management Ltd Limited Liability Company. Since August 28, 2017, it had 0 insider buys, and 3 selling transactions for $89,365 activity. $2.71M worth of Autodesk, Inc .Himax Technologies, Inc. (NASDAQ:HIMX) Analyst's Long Term Pick
A trend analysis is a method of analysis that allows traders to foresee what will come about with a stock in upcoming days. According to their predictions high & low revenue estimates are 4.26 Billion and 3.39 Billion respectively. -
Important Analyst Opinions: Pepsico, Inc. (PEP), Philip Morris International, Inc. (PM)
As per Thursday, March 24, the company rating was upgraded by Bank of America. (NYSE:PM) on Friday, October 13 with "Buy" rating. A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. (NYSE:PM).
26 January 2018Missing Anti-Trump Texts Found By DOJ, Mueller May Be Compromised
One of the texts spoke about an "insurance policy" against Trump during his presidential campaign. Page had left the investigative team two weeks prior, reportedly due to an unrelated reason.
26 January 2018Jose Mourinho Talks Potential Cristiano Ronaldo Transfer, Alexis Sanchez's Debut
Speaking to Arsenal Player, Mkhitaryan said he was looking forward to joining up with the likes of Ozil and co.at the Emirates. Mourinho has enjoyed huge success with Manchester United since coming over from rival Chelsea on May 27, 2016. -
26 January 2018Chronicler of Himalayan expedition passes away in Nepal
She had been chronicling hiking expeditions on the Himalayas for over 50 years and died in Nepal at the ripe old age of 94. She gave up her job as a researcher for Fortune magazine in NY after she visited Nepal on a round-the-world trip.
26 January 2018Mich. State's Legal Troubles Not Over After Prez Resigns
President Lou Anna Simon resigned. "As tragedies are politicized, blame is inevitable", Simon said in her resignation letter. A victim, Rachael Denhollander, said Michigan State was "compounding the damage" by the way it responded to the scandal.United Kingdom health body calls for cigarette-style warnings on alcohol
Warnings are now mandatory on most products "from tobacco to food and soft drinks, but alcohol continues to lag behind. "The UK is facing an alcohol health awareness vacuum, and poor labelling is partially to blame".
